Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Neonmind Biosciences Inc (OP: NMDBF ) N/A UNCHANGED Last Price Updated: 10:22 AM EST, Dec 14, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Neonmind Biosciences Inc < Previous 1 2 Next > World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them August 30, 2022 The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business... Via Benzinga Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved April 25, 2022 Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami... Via Benzinga NeonMind To Improve Patient Care And Data Management With Thrive Health's Digital Healthcare Platform April 22, 2022 NeonMind Biosciences Inc. Via Benzinga NeonMind To Launch 10 Mental Health Clinics In Canada, How Will Patients Benefit? April 13, 2022 NeonMind Biosciences Inc. (CSE:NEON) (OTCQB: NMDBF) (FRA:6UF) plans to launch 10 specialty mental health clinics over the next 3 years through alliances with SRx Health Solutions and BioScript... Via Benzinga NeonMind Announces Plan to Launch 10 Clinics for Innovative Treatments as Mental Health Crisis Grows April 12, 2022 Partnered with SRx Health Solutions and BioScript Solutions to Build Out a Network of NeonMind-branded Specialty Mental Health Clinics Across Canada OAKVILLE, ON / ACCESSWIRE / April 12, 2022 /... From NeonMind Biosciences Inc. Via AccessWire Psyched: Third Michigan City Decriminalizes Psychedelics, MindMed Reports $133M Cash Position, Real Brands To Enter The Space March 29, 2022 The psychedelics legislative landscape continues to move forward with Hazel Park,Michiganenacting decriminalization ... Via Benzinga NeonMind Files Provisional Patent Application For Psilocybin Induced Weight Loss March 22, 2022 NeonMind Biosciences Inc. (OTCQB: NMDBF) (CSE: NEON) (FRA:6UF) has filed a new patent application with the U.S. Patent and ... Via Benzinga Psyched: Albert Labs Goes Public, Ex-Moderna Executive Joins MAPS, Novamind and Usona Join For Phase 2 Psilocybin Trial March 15, 2022 A new company has entered the public psychedelic markets, with an alternative drug-to-market approach. UsingReal World ... Via Benzinga NeonMind Completes Pre-IND Consultation With FDA And Strengthens Medical Services Division March 10, 2022 NeonMind Biosciences Inc.(OTCQB: NMDBF) (CSE: NEON) (FRA:6UF) provided a summary of business highlights on the ... Via Benzinga Psyched: First Australian Psych Company On Nasdaq, Utah's Psychedelics Bill, LSD Vs. Psilocybin Study Unprecedented Results March 07, 2022 On the legislative front of the psychedelics space, a new bill meant to study the therapeutic effects of psychedelic substances ... Via Benzinga NeonMind Teams Up With BioScript Solutions To Expand Its Clinic Network For Interventional Psychiatry Treatments March 03, 2022 Psychedelic drug company NeonMind Biosciences Inc. (CSE:NEON)... Via Benzinga Cannabis Movers & Shakers: MedMen, Organigram, NeonMind, Green Check Verified February 24, 2022 Former Tilray Exec Ana Bowman Joins MedMen As CFO MedMen Enterprises Inc. (CSE: Via Benzinga NeonMind Appoints Dr. Dinesh Bhayana As Site Medical Director Of Its First Mental Health Clinic February 24, 2022 NeonMind Biosciences Inc. (CSE:NEON)(OTCQB: Via Benzinga NeonMind To Open Its First Specialty Mental Health Clinic In Ontario, More To Come February 17, 2022 Psychedelics company NeonMind Biosciences Inc. (OTCQB:NMDBF Via Benzinga Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th February 09, 2022 The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022,... Via Benzinga NeonMind to Present at H.C. Wainwright 2nd Annual Psychedelics Virtual Conference December 02, 2021 VANCOUVER, BC / ACCESSWIRE / December 2, 2021 / NeonMind Biosciences Inc. (CSE:NEON) (OTCQB:NMDBF) (FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused... From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate NEO-001 November 23, 2021 - FDA feedback provides clear clinical path for NEO-001, the first obesity drug therapy focused on neuropharmacological and behavioral changes for sustainable weight loss - Company plans to file an IND... From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety NeonMind to Participate in Panel Discussion at Lift & Co. Expo's Psychedelics Business Summit on November 19, 2021 November 17, 2021 VANCOUVER, BC / ACCESSWIRE / November 17, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company, is... From NeonMind Biosciences Inc. Via AccessWire Topics Cannabis Intellectual Property Exposures Cannabis Intellectual Property NeonMind and SRx Health Solutions Announce Strategic Alliance to Establish Specialty Mental Health Clinics for Interventional Psychiatry Treatments November 08, 2021 VANCOUVER, BC / ACCESSWIRE / November 8, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company, today... From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property NeonMind Biosciences Named as a Top Industry Innovator in Inaugural Issue of Psychedelia Magazine November 05, 2021 Announces Participation in Microdose's Wonderland: Miami on November 8-9, 2021 VANCOUVER, BC / ACCESSWIRE / November 5, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind"),... From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property NeonMind Advances Strategy for Specialty Clinic Launch September 28, 2021 Company expects to launch first specialty clinic locations by early 2022 NeonMind-branded specialty mental health clinics to bring innovative interventional psychiatry treatments to underserved... From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation October 18, 2021 The Week In Psychedelics Via Benzinga NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhD. September 22, 2021 Company Continues to Expand Its Scientific Expertise with Noted Expert in Utilizing Ketamine for Treatment Resistant Depression VANCOUVER, BC / ACCESSWIRE / September 22, 2021 / NeonMind Biosciences... From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are October 13, 2021 Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... Via Benzinga NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board September 16, 2021 Company Broadens Scientific Expertise with Addition of Mental Health Expert in Setting Up and Managing Interventional Psychiatric Clinics VANCOUVER, BC / ACCESSWIRE / September 16, 2021 / NeonMind... From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property NeonMind Announces Divestiture of Consumer Related and Other Non-Core Assets September 13, 2021 Reflects Strategic Focus on Psychedelic Treatments with Major Milestones in 2021 VANCOUVER, BC / ACCESSWIRE / September 13, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF)... From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety NeonMind to Present at H.C. Wainwright 23rd Annual Global Investment Conference September 08, 2021 VANCOUVER, BC / ACCESSWIRE / September 8, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind''or the "Company"), an integrated drug development and wellness company focused on... From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property NeonMind Announces DTC Eligibility August 25, 2021 VANCOUVER, BC / ACCESSWIRE / August 25, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FFE:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on... From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property NeonMind Receives Health Canada Approval for its Functional Mushroom Formulation 'Mindful Blend' August 17, 2021 VANCOUVER, BC / ACCESSWIRE / August 17, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FFE:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on... From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property NeonMind Announces Corporate Update and Strategic Reorganization of its Pharmaceutical Division August 05, 2021 - Designed to Accelerate Execution of Integrated Drug Development Plan for NEO-001 to Treat Obesity - Establishes R&D Advisory Board, Appoints Philippe Martin as Chairman - Expands Regulatory... From NeonMind Biosciences Inc. Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
